1. Home
  2. MLYS vs KRT Comparison

MLYS vs KRT Comparison

Compare MLYS & KRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • KRT
  • Stock Information
  • Founded
  • MLYS 2019
  • KRT 2000
  • Country
  • MLYS United States
  • KRT United States
  • Employees
  • MLYS N/A
  • KRT N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • KRT Plastic Products
  • Sector
  • MLYS Health Care
  • KRT Industrials
  • Exchange
  • MLYS Nasdaq
  • KRT Nasdaq
  • Market Cap
  • MLYS 634.6M
  • KRT 592.3M
  • IPO Year
  • MLYS 2023
  • KRT 2021
  • Fundamental
  • Price
  • MLYS $9.77
  • KRT $30.73
  • Analyst Decision
  • MLYS Strong Buy
  • KRT Buy
  • Analyst Count
  • MLYS 2
  • KRT 3
  • Target Price
  • MLYS $30.00
  • KRT $32.00
  • AVG Volume (30 Days)
  • MLYS 266.6K
  • KRT 35.8K
  • Earning Date
  • MLYS 11-11-2024
  • KRT 03-13-2025
  • Dividend Yield
  • MLYS N/A
  • KRT 3.42%
  • EPS Growth
  • MLYS N/A
  • KRT N/A
  • EPS
  • MLYS N/A
  • KRT 1.41
  • Revenue
  • MLYS N/A
  • KRT $416,566,000.00
  • Revenue This Year
  • MLYS N/A
  • KRT $5.39
  • Revenue Next Year
  • MLYS N/A
  • KRT $7.27
  • P/E Ratio
  • MLYS N/A
  • KRT $21.76
  • Revenue Growth
  • MLYS N/A
  • KRT 3.43
  • 52 Week Low
  • MLYS $8.58
  • KRT $23.10
  • 52 Week High
  • MLYS $16.91
  • KRT $33.14
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 37.52
  • KRT 57.89
  • Support Level
  • MLYS $9.18
  • KRT $29.01
  • Resistance Level
  • MLYS $9.97
  • KRT $29.74
  • Average True Range (ATR)
  • MLYS 0.85
  • KRT 0.89
  • MACD
  • MLYS -0.25
  • KRT 0.07
  • Stochastic Oscillator
  • MLYS 24.53
  • KRT 96.89

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About KRT Karat Packaging Inc.

Karat Packaging Inc is engaged in the manufacturing and distribution of disposable products used in restaurants and food service settings. It offers products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery, and straws. These products are available in plastic, paper, biopolymer-based and other compostable forms. Its product line includes a variety of brands such as Tea Zone, Karat, Karat Earth, and Total Clean.

Share on Social Networks: